Transmembrane Protein 230 (TMEM230) is a newly identified protein associated with Parkinson’s disease (PD) found in Lewy bodies and Lewy neurites of patients with PD or dementia with Lewy body disease. However, TMEM230 has not yet been investigated in the most common neurodegenerative disorder, Alzheimer’s disease (AD). Here, we demonstrate that the expression of TMEM230 is specifically increased in neurons in AD patients. Importantly, both granulovacuolar degeneration (GVD) and dystrophic neurites (DNs), two prominent characteristic pathological structures associated with AD, contain TMEM230 aggregates. TMEM230 immunoreactivity can be detected in neurofibrillary tangles-containing neurons and hyperphosphorylated tau positive DNs. TMEM230 accumulation is also noted around senile plaques. These findings identifying TMEM230 as a component of GVD and DNs suggest TMEM230 dysregulation as a likely mechanism playing an important role in the pathogenesis of AD.
SmithMA (1998) Alzheimer disease. Int Rev Neurobiol42, 1–54.
2.
BallMJ (1977) Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol37, 111–118.
3.
BallMJ, LoP (1977) Granulovacuolar degeneration in the ageing brain and in dementia. J Neuropathol Exp Neurol36, 474–487.
4.
Serrano-PozoA, FroschMP, MasliahE, HymanBT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med1, a006189.
5.
YamazakiY, MatsubaraT, TakahashiT, KurashigeT, DohiE, HijiM, NaganoY, YamawakiT, MatsumotoM (2011) Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders. PLoS One6, e26996.
6.
DicksonDW, Ksiezak-RedingH, DaviesP, YenSH (1987) A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration. Acta Neuropathol73, 254–258.
7.
KumarS, WirthsO, StuberK, WunderlichP, KochP, TheilS, Rezaei-GhalehN, ZweckstetterM, BayerTA, BrustleO, ThalDR, WalterJ (2016) Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity. Acta Neuropathol131, 525–537.
8.
GamblinTC, ChenF, ZambranoA, AbrahaA, LagalwarS, GuillozetAL, LuM, FuY, Garcia-SierraF, LaPointeN, MillerR, BerryRW, BinderLI, CrynsVL (2003) Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc Natl Acad Sci U S A100, 10032–10037.
9.
GervaisFG, XuD, RobertsonGS, VaillancourtJP, ZhuY, HuangJ, LeBlancA, SmithD, RigbyM, ShearmanMS, ClarkeEE, ZhengH, Van Der PloegLH, RuffoloSC, ThornberryNA, XanthoudakisS, ZamboniRJ, RoyS, NicholsonDW (1999) Involvement of caspases in proteolytic cleavage of Alzheimer’s amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell97, 395–406.
10.
IshizawaT, SaharaN, IshiguroK, KershJ, McGowanE, LewisJ, HuttonM, DicksonDW, YenSH (2003) Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol163, 1057–1067.
11.
KannanayakalTJ, TaoH, VandreDD, KuretJ (2006) Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions. Acta Neuropathol111, 413–421.
12.
PeersMC, LendersMB, DefossezA, DelacourteA, MazzucaM (1988) Cortical angiopathy in Alzheimer’s disease: The formation of dystrophic perivascular neurites is related to the exudation of amyloid fibrils from the pathological vessels. Virchows Arch A Pathol Anat Histopathol414, 15–20.
13.
CrasP, KawaiM, LoweryD, Gonzalez-DeWhittP, GreenbergB, PerryG (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A88, 7552–7556.
NixonRA, WegielJ, KumarA, YuWH, PeterhoffC, CataldoA, CuervoAM (2005) Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol64, 113–122.
20.
KimMJ, DengHX, WongYC, SiddiqueT, KraincD (2017) The Parkinson’s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking. Hum Mol Genet26, 729–741.
HunterS, MinettT, PolvikoskiT, Mukaetova-LadinskaE, BrayneC, CohortCCO-S (2015) Re-examining tau-immunoreactive pathology in the population: Granulovacuolar degeneration and neurofibrillary tangles. Alzheimers Res Ther7, 57.
23.
Cuchillo-IbanezI, SeereeramA, ByersHL, LeungKY, WardMA, AndertonBH, HangerDP (2008) Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin. FASEB J22, 3186–3195.
24.
KeckS, NitschR, GruneT, UllrichO (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer’s disease. J Neurochem85, 115–122.
